Bioconversion of AS1387392: Bioconversion studies involving Amycolatopsis azurea JCM 3275

Journal of Antibiotics

Volumn 63, Issue 11, 2010, Pages 643-647

  Sasamura, Satoshi ^a   Ohsumi, Keisuke ^a   Takase, Shigehiro ^a   Yamada, Toshiko ^a,b   Muramatsu, Hideyuki ^a   Fujie, Akihiko ^a   Mori, Hiroaki ^a,c   Fujii, Takashi ^a,c   Hino, Motohiro ^a   Sakamoto, Kazutoshi ^a   Hashimoto, Michizane ^a  

^a ASTELLAS PHARMA INC   (Japan)

^b ASTELLAS PHARMA GLOBAL DEVELOPMENT   (United States)

^c Kaketsuken   (Japan)

Author keywords

Amycolatopsis azurea; AS1387392; AS1429716; bioconversion; histone deacetylase inhibitor; immunosuppressant

Indexed keywords

ANTIINFECTIVE AGENT; AS 1387392; AS 1429716; CARBON; IMMUNOSUPPRESSIVE AGENT; KETOL; NITROGEN; PHENYLALANINE; UNCLASSIFIED DRUG;

ACTINOBACTERIA; AMYCOLATOPSIS AZUREA; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CULTURE MEDIUM; DERIVATIZATION; DRUG HYDROXYLATION; DRUG ISOLATION; DRUG SCREENING; DRUG TRANSFORMATION; HUMAN; HUMAN CELL; NONHUMAN; PH; PRIORITY JOURNAL;

ACTINOMYCETALES; CARBON; CULTURE MEDIA; HYDROGEN-ION CONCENTRATION; HYDROXYLATION; IMMUNOSUPPRESSIVE AGENTS; NITROGEN; PEPTIDES, CYCLIC; TEMPERATURE;

ACTINOBACTERIA (CLASS); AMYCOLATOPSIS AZUREA;

EID: 78649676650     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2010.108     Document Type: Article

References (10)

1. Sasamura, S. et al. AS1387392, a novel immunosuppressivecyclictetrapeptidecompound with inhibitory activity against mammalian histone deacetylase. J. Antibiot. (e-pub ahead of print 30 June 2010; doi:10.1038/Ja.2010.51).
2. Serizawa, N., Serizawa, S., Furuya, K., Okazaki, T. & Terahara, A. Microbial hydroxyla-tion of ML-236B (compactin). Studies on microorganisms capable of 3 beta-hydro-xylation of ML-236B. J. Antibiot. 36, 887-891 (1983).
3. Sasaki, J. et al. Transformation of vitamine D3 to 1α, 25-dihydroxyvitamine D3 via 25-hydroxyvitamine D3 using Amycolata sp. strains. Appl. Microbiol. Biotechnol. 38, 152-157 (1992).
4. Schulman, M., Doherty P., Zink, D. & Arison, B. Microbial conversion of avermectins by Saccharopolyspora erthraea hydroxylation at C-27. J. Antibiot. 47, 372-375 (1994).
5. Nakagawa, K. & Torikata, A. Microbial conversion of milbemycins: 30-oxidation of milbemycin A4 and related compounds by Amycolatata autotrophica and amycolatopsis mediterranei. J. Antibiot. 43, 1321-1328 (1990).
6. Hall, R. M. et al. The production of novel sordarin analogues by transformation. J. Antibiot. 54, 948-957 (2001).
7. Sasamura, S. et al. Bioconversion of AS1387392: screening and characterization of actinomycetes that convert AS1387392 to AS1429716. J. Antibiot. (e-pub ahead of print 28 July 2010; doi:10.1038/Ja.2010.89).
8. Mori, H. et al. FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase (HDAC). I. Taxonomy, fermentation, isolation and biological activities. J. Antibiot. 56, 72-79 (2003). (Pubitemid 36372787)
9. Ueno, M. et al. Cloning and heterologous expression of P450Um-1, a novel bacterial P450 gene, for hydroxylation of immunosuppressive agent AS1387392. J. Antibiot. (e-pub ahead of print 6 October 2010; doi:10.1038/Ja.2010.109).
10. Kijima, M., Yoshida, M., Sugita, K., Horinouchi, S. & Beppu, T. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J. Biol. Chem. 268, 22429-22435 (1993).